News & Resources
Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.
-
Redesigning Reach: Community-Based Research In Action – Part 2
Our series highlighting industry perspectives on community-based research continues. In partnership with Citeline, we surveyed 130 leaders from biotech companies, pharmaceutical organizations, and CROs to understand how they view emerging community‑centric efforts to bring trials closer to patients. In part 1, we explored the key findings from the survey. Here, we take a closer look […]
-
EmVenio attends SCOPE 2026
Last week, our team attended the 17th annual SCOPE Summit in Orlando, Florida. This year was especially meaningful as it marked our first time attending as EmVenio Clinical Research. We were excited to reconnect with partners, meet new faces, and share how our community-based approach is transforming access to research. Showcasing Leadership in Decentralized Clinical Trials We kicked off the week with […]
-
New FDA Guidance: Further Enhancing Clinical Trial Participation
In December 2025, the U.S. Food and Drug Administration (FDA) released a new guidance focused on improving participation in clinical trials. The guidance provides updated recommendations to increase patient enrollment among representative populations in clinical research. Its goal is to ensure that clinical trials for drugs and biologics reflect the […]
-
How Does Community-Based Research Deliver Faster Results and Greater Access
Community‑based research models are reshaping the clinical trial landscape by bringing studies closer to the populations they serve. Traditional site‑based models often introduce geographic, logistical, and cultural barriers that limit access to participation. Community‑based approaches reverse this dynamic by meeting patients where they are, fostering trust, and improving access without […]
-
Redesigning Reach: Community-Based Research In Action – Part 1
We recently partnered with Citeline to explore how industry leaders view clinical trials and the growing shift toward community-based research. To better understand these trends, we surveyed 130 leaders from biotech companies, pharmaceuticals and CROs to get their thoughts on community-based research and its effectiveness in bringing trials closer to […]
-
Year-in-Review: EmVenio in 2025
This year marks the most transformative chapter in EmVenio’s history! From our rebrand to clinical trial facilitation to the conference circuit, we covered a lot of ground this year. Here are some of the highlights of 2025. The things we did. Our rebrand was a major accomplishment in 2025. Earlier […]
-
EmVenio builds personal connections at community kidney walks
Community connection and trust are major components of any successful clinical trial. At EmVenio, we focus on building genuine, lasting relationships in the communities we serve – bridging the gap between people and science. Our teams create these connections through approachable conversations with community members and intentional partnerships with local […]
-
EmVenio to open research site at Chicago’s Saint Mary of Nazareth Hospital
EmVenio Clinical Research will open a dedicated community research site on the campus of Saint Mary of Nazareth Hospital in Chicago, Illinois. In 2024, EmVenio partnered with Prime Healthcare, operator of Saint Mary, to conduct clinical trials at its hospitals around the country, offering patients within the community improved access […]
-
EmVenio Showcases Human-Centered Innovation at the 2025 SCRS Global Site Solutions Summit
The Society of Clinical Research Sites has been a key part of our journey since day one. The SCRS Global Site Solutions Summit has been a highlight for our team each year, and this year was no different; We showed up in full force – with a fresh brand, bold […]
-
Unveiling the new EmVenio at DPHARM
Last week, several of our team members traveled to Philadelphia for the 15th Annual DPHARM conference. We enjoyed introducing EmVenio Clinical Research to attendees, following the alignment of PCM Trials and its subsidiaries, EmVenio Research and Clinical Trial Service, under one brand. This year’s theme – Disruptive Innovations to Modernize […]
-
Expanding Accessibility in a Phase 3 Influenza Study Through Community-Based Research: A Collaborative Case Study
This ongoing Phase 3 study seeks to evaluate the safety, efficacy, and immunogenicityof a new seasonal influenza vaccine compared to a licensed inactivated vaccinein adults aged 50 and older. Given the potential severity of influenza symptoms andinfluenza-related complications, ensuring broad participation and adherence to studyprotocols is essential.
-
Study Delivery: Case Study
A new partner contacted EmVenio Research for urgent help in conducting a device and usability study within a tight timeline that couldn’t be adjusted. Meeting both the deadlines and participant stratification criteria was crucial.
